Showing 1-10 of 531 results for "".

• Elizabeth Londen, PhD
  https://practicalneurology.com/profiles/elizabeth-londen-phd/Lgy1V1/
• Dr. Elizabeth Leroux, McGill University, Highlights Key Articles in Headache Literature from 2022-2023
  https://practicalneurology.com/news/dr-elizabeth-leroux-mcgill-university-highlights-key-articles-in-headache-literature-from-2022-2023/2470345/
  On the final day of the 2023 Scottsdale Headache Symposium, Dr. Elizabeth Leroux, Past President of the Canadian Headache Society, presented a review of the state of headache literature from 2022 through 2023. Dr. Leroux outlined key areas in scientific publications focusing on the following area
• CTAD 2025 Honors Takeshi Iwatsubo, MD, PhD with Lifetime Achievement Award
  https://practicalneurology.com/news/ctad-2025-honors-takeshi-iwatsubo-md-phd-with-lifetime-achievement-award/2484692/
  Takeshi Iwatsubo, MD, PhD was recognized at the 18th annual Clinical Trials on Alzheimer’s Disease (CTAD) conference as the recipient of this year’s Lifetime Achievement Award in Alzheimer’s Disease Therapeutic Research. The award celebrates Dr. Iwatsubo’s decades of foundational work in Alzheime
• Barancik Prize Awarded to Sergio E. Baranzini, PhD at ACTRIMS 2024
  https://practicalneurology.com/news/barancik-prize-awarded-to-sergio-e-baranzini-phd-at-actrims-2024/2470413/
  This year, the National Multiple Sclerosis Society has awarded Sergio E. Baranzini, PhD the prestigious Barancik Prize for Innovation in Multiple Sclerosis (MS) Research. Professor Baranzini is a geneticist, neuroimmunologist, and data scientist at the University of California, San Francisco (UCS
• 2024 Lifetime Achievement Award in Alzheimer’s Disease Therapeutic Research Presented to Lars Lannfelt, MD, PhD
  https://practicalneurology.com/news/2024-lifetime-achievement-award-in-alzheimers-disease-therapeutic-research-presented-to-lars-lannfelt-md-phd/2470618/
  Lars Lannfelt, MD, PhD has been recognized as the recipient of the 2024 Lifetime Achievement Award in Alzheimer’s Disease Therapeutic Research at the 17th annual Clinical Trials on Alzheimer’s Disease (CTAD) conference. Dr. Lannfelt was selected based on his pioneering work in Alzheim
• First Visualization of PINK1 Protein Structure Reveals Critical Parkinson Disease Mechanisms
  https://practicalneurology.com/news/first-visualization-of-pink1-protein-structure-reveals-critical-parkinson-disease-mechanisms/2473904/
  The first ever visualization of how the PINK1 protein docks to the surface of mitochondria was developed by researchers at the Walter and Elizabeth Hall Institute (WEHI), Melbourne, Australia. The findings, which are published in Science, elucidate key information about the beha

• About The Cover Artist

  https://practicalneurology.com/diseases-diagnoses/imaging-testing/about-the-cover-artist/30205/
  Elizabeth Jameson explores the intersection of art and science through her own brain scans of multiple sclerosis lesions.
  • Text

• About the Cover Artist: Purple Phoenix by Denis Ducreux, MD, PhD

  https://practicalneurology.com/diseases-diagnoses/imaging-testing/about-the-cover-artist-purple-phoenix-by-denis-ducreux-md-phd/56388/
  Dr. Ducreux’s artwork originates in diffusion-based MRI studies that reveal the organization of white matter pathways. 
  • Text

• Monoclonal Antibody Studies

  https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/monoclonal-antibody-studies/30233/
  An Interview with Rachelle S. Doody, MD, PhD
  • Text

• Seeking Breakthroughs: The Startup Perspective

  https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-startup-perspective/30194/
  A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin Therapeutics
  • Text

• Prev
• 1
• 2
• 3
• …
• 53
• 54
• Next